Parallel imports of pharmaceutical products in the European Union:
Parallel imports are legitimately produced goods imported legally into a country without the authorization of a trademark, copyright, or patent holder. In the European Union, so long as a pharmaceutical manufacturer has placed a good on the market voluntarily, the principle of free movement of goods...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Washington, D.C
World Bank, Development Research Group, Trade
2001
|
| Schriftenreihe: | Policy research working paper
2630 |
| Schlagworte: | |
| Online-Zugang: | BSB01 EUV01 HTW01 FHI01 IOS01 Volltext |
| Zusammenfassung: | Parallel imports are legitimately produced goods imported legally into a country without the authorization of a trademark, copyright, or patent holder. In the European Union, so long as a pharmaceutical manufacturer has placed a good on the market voluntarily, the principle of free movement of goods allows individuals or firms within the EU to trade goods across borders without the consent of the producer. What is the effect of these parallel imports? |
| Beschreibung: | "July 2001 Includes bibliographical references (p. 22) Title from title screen as viewed on Sept. 07, 2002 |
| Beschreibung: | 1 Online-Ressource |
Internformat
MARC
| LEADER | 00000nmm a22000001cb4500 | ||
|---|---|---|---|
| 001 | BV049075963 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 230731s2001 xxu|||| o||u| ||||||eng d | ||
| 035 | |a (ZDB-1-WBA)093212143 | ||
| 035 | |a (OCoLC)1392149836 | ||
| 035 | |a (DE-599)GBVNLM005448298 | ||
| 040 | |a DE-604 |b ger | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c XD-US | ||
| 049 | |a DE-12 |a DE-521 |a DE-573 |a DE-523 |a DE-Re13 | ||
| 100 | 1 | |a Ganslandt, Mattias |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Parallel imports of pharmaceutical products in the European Union |c Mattias Ganslandt and Keith E. Maskus |
| 264 | 1 | |a Washington, D.C |b World Bank, Development Research Group, Trade |c 2001 | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Policy research working paper |v 2630 | |
| 500 | |a "July 2001 | ||
| 500 | |a Includes bibliographical references (p. 22) | ||
| 500 | |a Title from title screen as viewed on Sept. 07, 2002 | ||
| 520 | 3 | |a Parallel imports are legitimately produced goods imported legally into a country without the authorization of a trademark, copyright, or patent holder. In the European Union, so long as a pharmaceutical manufacturer has placed a good on the market voluntarily, the principle of free movement of goods allows individuals or firms within the EU to trade goods across borders without the consent of the producer. What is the effect of these parallel imports? | |
| 533 | |a Online-Ausg |n Also available in print | ||
| 650 | 4 | |a Drugs |x Prices |z European Union countries |v Econometric models | |
| 650 | 4 | |a Gray market |z European Union countries |v Econometric models | |
| 650 | 4 | |a Imports |z European Union countries |v Econometric models | |
| 650 | 4 | |a Price regulation |z European Union countries |v Econometric models | |
| 650 | 4 | |a Trademarks (International law) |v Econometric models | |
| 700 | 1 | |a Maskus, Keith Eugene |e Sonstige |4 oth | |
| 710 | 2 | |a World Bank |e Development Research Group |e Trade |4 oth | |
| 776 | 0 | 8 | |i Ganslandt, Mattias |a Parallel imports of pharmaceutical products in the European Union |
| 856 | 4 | 0 | |u http://elibrary.worldbank.org/content/workingpaper/10.1596/1813-9450-2630 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-1-WBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-034337854 | ||
| 966 | e | |u http://elibrary.worldbank.org/content/workingpaper/10.1596/1813-9450-2630 |l BSB01 |p ZDB-1-WBA |x Verlag |3 Volltext | |
| 966 | e | |u http://elibrary.worldbank.org/content/workingpaper/10.1596/1813-9450-2630 |l EUV01 |p ZDB-1-WBA |x Verlag |3 Volltext | |
| 966 | e | |u http://elibrary.worldbank.org/content/workingpaper/10.1596/1813-9450-2630 |l HTW01 |p ZDB-1-WBA |x Verlag |3 Volltext | |
| 966 | e | |u http://elibrary.worldbank.org/content/workingpaper/10.1596/1813-9450-2630 |l FHI01 |p ZDB-1-WBA |x Verlag |3 Volltext | |
| 966 | e | |u http://elibrary.worldbank.org/content/workingpaper/10.1596/1813-9450-2630 |l IOS01 |p ZDB-1-WBA |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804185396113833984 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Ganslandt, Mattias |
| author_facet | Ganslandt, Mattias |
| author_role | aut |
| author_sort | Ganslandt, Mattias |
| author_variant | m g mg |
| building | Verbundindex |
| bvnumber | BV049075963 |
| collection | ZDB-1-WBA |
| ctrlnum | (ZDB-1-WBA)093212143 (OCoLC)1392149836 (DE-599)GBVNLM005448298 |
| discipline | Wirtschaftswissenschaften |
| discipline_str_mv | Wirtschaftswissenschaften |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02969nmm a22005171cb4500</leader><controlfield tag="001">BV049075963</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">230731s2001 xxu|||| o||u| ||||||eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-1-WBA)093212143</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1392149836</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBVNLM005448298</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">XD-US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-521</subfield><subfield code="a">DE-573</subfield><subfield code="a">DE-523</subfield><subfield code="a">DE-Re13</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ganslandt, Mattias</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Parallel imports of pharmaceutical products in the European Union</subfield><subfield code="c">Mattias Ganslandt and Keith E. Maskus</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C</subfield><subfield code="b">World Bank, Development Research Group, Trade</subfield><subfield code="c">2001</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Policy research working paper</subfield><subfield code="v">2630</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"July 2001</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (p. 22)</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Title from title screen as viewed on Sept. 07, 2002</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">Parallel imports are legitimately produced goods imported legally into a country without the authorization of a trademark, copyright, or patent holder. In the European Union, so long as a pharmaceutical manufacturer has placed a good on the market voluntarily, the principle of free movement of goods allows individuals or firms within the EU to trade goods across borders without the consent of the producer. What is the effect of these parallel imports?</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="a">Online-Ausg</subfield><subfield code="n">Also available in print</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Prices</subfield><subfield code="z">European Union countries</subfield><subfield code="v">Econometric models</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gray market</subfield><subfield code="z">European Union countries</subfield><subfield code="v">Econometric models</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Imports</subfield><subfield code="z">European Union countries</subfield><subfield code="v">Econometric models</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Price regulation</subfield><subfield code="z">European Union countries</subfield><subfield code="v">Econometric models</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Trademarks (International law)</subfield><subfield code="v">Econometric models</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Maskus, Keith Eugene</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">World Bank</subfield><subfield code="e">Development Research Group</subfield><subfield code="e">Trade</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Ganslandt, Mattias</subfield><subfield code="a">Parallel imports of pharmaceutical products in the European Union</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://elibrary.worldbank.org/content/workingpaper/10.1596/1813-9450-2630</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-WBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-034337854</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://elibrary.worldbank.org/content/workingpaper/10.1596/1813-9450-2630</subfield><subfield code="l">BSB01</subfield><subfield code="p">ZDB-1-WBA</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://elibrary.worldbank.org/content/workingpaper/10.1596/1813-9450-2630</subfield><subfield code="l">EUV01</subfield><subfield code="p">ZDB-1-WBA</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://elibrary.worldbank.org/content/workingpaper/10.1596/1813-9450-2630</subfield><subfield code="l">HTW01</subfield><subfield code="p">ZDB-1-WBA</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://elibrary.worldbank.org/content/workingpaper/10.1596/1813-9450-2630</subfield><subfield code="l">FHI01</subfield><subfield code="p">ZDB-1-WBA</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://elibrary.worldbank.org/content/workingpaper/10.1596/1813-9450-2630</subfield><subfield code="l">IOS01</subfield><subfield code="p">ZDB-1-WBA</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV049075963 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T22:27:49Z |
| indexdate | 2024-07-10T09:54:34Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034337854 |
| oclc_num | 1392149836 |
| open_access_boolean | |
| owner | DE-12 DE-521 DE-573 DE-523 DE-Re13 DE-BY-UBR |
| owner_facet | DE-12 DE-521 DE-573 DE-523 DE-Re13 DE-BY-UBR |
| physical | 1 Online-Ressource |
| psigel | ZDB-1-WBA |
| publishDate | 2001 |
| publishDateSearch | 2001 |
| publishDateSort | 2001 |
| publisher | World Bank, Development Research Group, Trade |
| record_format | marc |
| series2 | Policy research working paper |
| spelling | Ganslandt, Mattias Verfasser aut Parallel imports of pharmaceutical products in the European Union Mattias Ganslandt and Keith E. Maskus Washington, D.C World Bank, Development Research Group, Trade 2001 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Policy research working paper 2630 "July 2001 Includes bibliographical references (p. 22) Title from title screen as viewed on Sept. 07, 2002 Parallel imports are legitimately produced goods imported legally into a country without the authorization of a trademark, copyright, or patent holder. In the European Union, so long as a pharmaceutical manufacturer has placed a good on the market voluntarily, the principle of free movement of goods allows individuals or firms within the EU to trade goods across borders without the consent of the producer. What is the effect of these parallel imports? Online-Ausg Also available in print Drugs Prices European Union countries Econometric models Gray market European Union countries Econometric models Imports European Union countries Econometric models Price regulation European Union countries Econometric models Trademarks (International law) Econometric models Maskus, Keith Eugene Sonstige oth World Bank Development Research Group Trade oth Ganslandt, Mattias Parallel imports of pharmaceutical products in the European Union http://elibrary.worldbank.org/content/workingpaper/10.1596/1813-9450-2630 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Ganslandt, Mattias Parallel imports of pharmaceutical products in the European Union Drugs Prices European Union countries Econometric models Gray market European Union countries Econometric models Imports European Union countries Econometric models Price regulation European Union countries Econometric models Trademarks (International law) Econometric models |
| title | Parallel imports of pharmaceutical products in the European Union |
| title_auth | Parallel imports of pharmaceutical products in the European Union |
| title_exact_search | Parallel imports of pharmaceutical products in the European Union |
| title_exact_search_txtP | Parallel imports of pharmaceutical products in the European Union |
| title_full | Parallel imports of pharmaceutical products in the European Union Mattias Ganslandt and Keith E. Maskus |
| title_fullStr | Parallel imports of pharmaceutical products in the European Union Mattias Ganslandt and Keith E. Maskus |
| title_full_unstemmed | Parallel imports of pharmaceutical products in the European Union Mattias Ganslandt and Keith E. Maskus |
| title_short | Parallel imports of pharmaceutical products in the European Union |
| title_sort | parallel imports of pharmaceutical products in the european union |
| topic | Drugs Prices European Union countries Econometric models Gray market European Union countries Econometric models Imports European Union countries Econometric models Price regulation European Union countries Econometric models Trademarks (International law) Econometric models |
| topic_facet | Drugs Prices European Union countries Econometric models Gray market European Union countries Econometric models Imports European Union countries Econometric models Price regulation European Union countries Econometric models Trademarks (International law) Econometric models |
| url | http://elibrary.worldbank.org/content/workingpaper/10.1596/1813-9450-2630 |
| work_keys_str_mv | AT ganslandtmattias parallelimportsofpharmaceuticalproductsintheeuropeanunion AT maskuskeitheugene parallelimportsofpharmaceuticalproductsintheeuropeanunion AT worldbank parallelimportsofpharmaceuticalproductsintheeuropeanunion |